Open access
15
Views
0
CrossRef citations to date
0
Altmetric
RESPONSE TO LETTER
Critique on “Real-World Effectiveness of First-Line Lenvatinib Therapy in Advanced Hepatocellular Carcinoma: Current Insights” [Response to Letter]
Tiago Biachi de Castria1 Department of Gastrointestinal Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA;2 Morsani College of Medicine, University of South Florida, Tampa, FL, USA
& Richard D Kim1 Department of Gastrointestinal Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA;2 Morsani College of Medicine, University of South Florida, Tampa, FL, USACorrespondence[email protected]
https://orcid.org/0000-0002-8448-844X
Pages 91-92
|
Received 24 Jun 2024, Accepted 24 Jun 2024, Published online: 09 Jul 2024
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.